Most public-affairs firms sell access or attention. Woodberry Associates sells the harder thing: a system for turning policy, data and scattered constituencies into coordinated action.
Venn Strategies sells access, policy fluency and persuasion. Then its founder made an unusually literal bet on alignment: she gave the people doing the work a stake in the firm.
CCR Consulting hires people who have already lived inside the systems its clients are trying to change. The result is a particular kind of consultancy: less crystal ball, more institutional memory with a project plan.
The Hershey consultancy does not sell attention for its own sake. It builds coalitions around the people whose trust a health company cannot manufacture - and measures what happens next.
Pyxis Partners has built a business translating between Washington's health-policy rooms and communities that have good reasons to distrust them. Its real product is not access alone. It is the patient work of making access travel both ways.
In Washington, access is usually sold to whoever can pay. Michael Waxman built a firm around a narrower proposition: policy, advocacy and communications for work it can defend in public.
A small policy firm built a business around an unglamorous advantage: noticing what changed, explaining why it matters, and doing it before everyone else catches up.
A therapy can clear the lab and still stall at a code, a coverage rule, or a committee door. Jeffrey J. Kimbell & Associates built a business around that awkward final mile.
A small Washington firm found a lucrative gap between the laboratory and the legislature. Its job is to make good science legible to the people who fund it.